Roberto Reif
Boston University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Roberto Reif.
Applied Optics | 2007
Roberto Reif; Ousama M. A'Amar; Irving J. Bigio
Monte Carlo simulations and experiments in tissue phantoms were used to empirically develop an analytical model that characterizes the reflectance spectrum in a turbid medium. The model extracts the optical properties (scattering and absorption coefficients) of the medium at small source-detector separations, for which the diffusion approximation is not valid. The accuracy of the model and the inversion algorithm were investigated and validated. Four fiber probe configurations were tested for which both the source and the detector fibers were tilted at a predetermined angle, with the fibers parallel to each other. This parallel-fiber geometry facilitates clinical endoscopic applications and ease of fabrication. Accurate extraction of tissue optical properties from in vivo spectral measurements could have potential applications in detecting, noninvasively and in real time, epithelial (pre)cancers.
Journal of Biomedical Optics | 2008
Roberto Reif; Mark S. Amorosino; Katherine W. Calabro; Ousama M. A'Amar; Satish K. Singh; Irving J. Bigio
Spectral reflectance measurements of biological tissues have been studied for early diagnoses of several pathologies such as cancer. These measurements are often performed with a fiber optic probe in contact with the tissue surface. We report a study in which reflectance measurements are obtained in vivo from mouse thigh muscle while varying the contact pressure of the fiber optic probe. It is determined that the probe pressure is a variable that affects the local optical properties of the tissue. The reflectance spectra are analyzed with an analytical model that extracts the tissue optical properties and facilitates the understanding of underlying physiological changes induced by the probe pressure.
Journal of Biomedical Optics | 2007
Roberto Reif; Mei Wang; Shailendra Joshi; Ousama A’amar; Irving J. Bigio
The understanding of drug delivery to organs, such as the brain, has been hampered by the inability to measure tissue drug concentrations in real time. We report an application of an optical spectroscopy technique that monitors in vivo the real-time drug concentrations in small volumes of brain tissue. This method will facilitate development of new protocols for delivery of drugs to treat brain cancers. The delivery of many anticancer drugs to the brain is limited by the presence of the blood-brain barrier (BBB). Mitoxantrone (MTX) is a water-soluble anticancer drug that poorly penetrates the BBB. It is preliminarily determined in an animal model that the brain tissue uptake of chemotherapy agents-in this demonstration, MTX-delivered intra-arterially is enhanced when the BBB is disrupted.
Journal of Neuro-oncology | 2011
Shailendra Joshi; Aysegul Ergin; Mei Wang; Roberto Reif; Jane Zhang; Jeffrey N. Bruce; Irving J. Bigio
The novel ability to quantify drug and tracer concentrations in vivo by optical means leads to the possibility of detecting and quantifying blood brain barrier (BBB) disruption in real-time by monitoring concentrations of chromophores such as Evan’s Blue. In this study, experiments were conducted to assess the disruption of the BBB, by intraarterial injection of mannitol, in New Zealand white rabbits. Surgical preparation included: tracheotomy for mechanical ventilation, femoral and selective internal carotid artery (ICA) catheterizations, skull screws for monitoring electrocerebral activity, bilateral placement of laser Doppler probes and a small craniotomy for the placement of a fiber optic probe to determine tissue Evan’s Blue dye concentrations. Evans Blue (6.5xa0mg/kg) was injected intravenously (IV) just before BBB disruption with intracarotid mannitol (25%, 8xa0ml/40xa0s). Brain tissue concentrations of the dye in mannitol-treated and control animals were monitored using the method of optical pharmacokinetics (OP) during the subsequent 60xa0min. Hemodynamic parameters, heart rate, blood pressure, and EKG remained stable throughout the experiments in both the control and the mannitol-treated group. Brain tissue concentrations of Evan’s Blue and the brain:plasma Evan’s Blue partition coefficient progressively increased during the period of observation. A wide variation in brain tissue Evan’s Blue concentrations was observed in the mannitol group. The experiments demonstrate the feasibility of measuring tissue concentrations of Evan’s Blue without invading the brain parenchyma, and in real-time. The data suggest that there are significant variations in the degree and duration of BBB disruption induced with intraarterial mannitol. The ability to optically monitor the BBB disruption in real-time could provide a feedback control for hypertonic disruption and/or facilitate dosage control for chemotherapeutic drugs that require such disruption.
Neurosurgery | 2011
Shailendra Joshi; Roberto Reif; Mei Wang; Jane Zhang; Aysegul Ergin; Jeffery N. Bruce; Robert L. Fine; Irving J. Bigio
BACKGROUND:Several human studies have demonstrated the feasibility of intra-arterial delivery of mitoxantrone in systemic malignancies. Computational models predict that an intra-arterial bolus injection of mitoxantrone during transient cerebral hypoperfusion will enhance brain tissue drug deposition in comparison with injections during normal blood flow. OBJECTIVE:To assess whether transient reduction in cerebral blood flow would enhance the delivery of mitoxantrone. This is accomplished by obtaining real-time measurements of mitoxantrone concentrations in brain tissues by using a novel optical pharmacokinetics technique, based on reflectance spectroscopy. METHODS:The blood-brain barrier of anesthetized rabbits was disrupted by intracarotid injection of mannitol (8 mL, 25% over 40 seconds). Thereafter, animals received 3 mg of mitoxantrone injection during normal perfusion (n = 5) or cerebral hypoperfusion that was induced by contralateral arterial occlusion and systemic hypotension (n = 8). RESULTS:Cerebral hypoperfusion significantly decreased the cerebral blood flow, allowing a longer exposure time of the drug. It was determined that therapeutic concentrations of mitoxantrone were achieved in both groups; however, hypoperfusion did not increase the tissue concentrations of mitoxantrone after 20 minutes. CONCLUSION:These results demonstrate the effective delivery of mitoxantrone by the intra-arterial route, after blood-brain-barrier disruption, but the predicted benefits of flow reduction for improving intra-arterial deposition of mitoxantrone was not evident.
Proceedings of SPIE | 2007
Roberto Reif; Irving J. Bigio
In the study of epithelial tissues and superficial cancers, it is often important to determine the optical properties of small volumes of tissue, and at varying depths. A model that relates the reflectance spectrum to the optical properties of a turbid medium at small source-detector separations is developed based on Monte Carlo simulations and experiments in tissue phantoms. Four fiber probes are analyzed, for which each fiber probe presents a different tilt angle. Preliminary results show good correlation between known optical properties in tissue phantoms, and the measured optical properties.
Biosilico | 2006
Roberto Reif; Irving J. Bigio
Monte Carlo simulations are used to determine several fiber probe designs for which the effective pathlength of photons traveling in tissue is minimally sensitive to the scattering properties, enabling direct measurement of the absorption coefficient.
Archive | 2008
Irving J. Bigio; Roberto Reif; Ousama M. A'Amar
Archive | 2008
Amar Ousama A; Irving J. Bigio; Roberto Reif
IEEE Transactions on Biomedical Engineering | 2008
Roberto Reif; Yakov Gitin; Eladio Rodriguez-Diaz; Christopher D. Atkinson; Ousama M. A'Amar; Satish K. Singh; Irving J. Bigio